Lung cancer is one of the main causes of cancer-related deaths globally,with non-small cell lung cancer(NSCLC)being the most prevalent histological subtype of lung cancer.Glutathione peroxidase 4(GPX4)is a crucial ant...
supported by Zhejiang Major R&D programs(2021C03042);Key R&D Program of Zhejiang Respiratory Disease(2023C03069);Zhejiang Provincial Clinical Research Center for Respiratory Disease(2022E50005).
Osimertinib,a third-generation epidermal growth factor receptor tyrosine kinase inhibitor(EGFR-TKI),has demonstrated significant clinical benefits in the treatment of EGFR-mutated non-small cell lung cancer(NSCLC).How...
supported by Sichuan Province Central Government Guide Local Science and Technology Development Project(No.2023ZYD0169).
Background:Non-small cell lung cancer(NSCLC)is often accompanied by brain metastasis(BM),and the prognosis of patients with BM is poor.This study assesses the prognostic impact of BM in NSCLC patients with epidermal g...